MREO
Mereo BioPharma GroupBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
MREO vs peer average
75/100
MREO vs. peer average (B vs. D)
Grade spread
A 1 · B 1 · C 2 · D 5 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ALGS is the first available peer comparator.
Aligos is a loose same-cap clinical biotech comparator where valuation is also driven more by milestone timing and funding capacity than by current revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MREO
Mereo BioPharma Group
ALGS
Aligos Therapeutics
Grade
B
D
Momentum
91
65
Value
41
41
Sentiment
68
44
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ALGS
MREO / ALGS
Grade Position
Above peers
MREO vs. peer average (B vs. D)
75/100
Momentum
91
MREOValue
41
MREOSentiment
68
MREORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MREO
ALGS is the first peer returned for this comparison set.